DR. MAGDOLNA SOLTI MD NPI 1629062542

NPI Details

DR. Magdolna Solti, MD is a hematology and oncology internal medicine in Vancouver, WA with 34 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Magdolna Solti, MD NPI is 1629062542. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

210 SE 136TH AVE
VANCOUVER, WA
ZIP 98684-930
Phone: (360) 944-9889
Fax: (360) 944-9686

The NPI 1629062542 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Nephelometry, test method using light (HCPCS:83883)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, fulvestrant, 25 mg (HCPCS:J9395)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Vitamin d-3 level (HCPCS:82306)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Protein measurement, serum (HCPCS:84165)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Folic acid level, serum (HCPCS:82746)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Chromosome analysis for genetic defects, analyze 100-300 cells (HCPCS:88275)
• Ferritin (blood protein) level (HCPCS:82728)
• Total protein level, urine (HCPCS:84156)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Ct scan of chest with contrast (HCPCS:71260)
• Unclassified drugs (HCPCS:J3490)
• Alpha-fetoprotein (afp) level, serum (HCPCS:82105)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Magnesium level (HCPCS:83735)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Homocysteine (amino acid) level (HCPCS:83090)
• Injection of drug or substance into vein (HCPCS:96374)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Hepatitis b surface antibody measurement (HCPCS:86706)
• Ct scan of chest without contrast (HCPCS:71250)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Hepatitis c antibody measurement (HCPCS:86803)
• Phosphate level (HCPCS:84100)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Ct scan for measuring calcium and other minerals in bone (HCPCS:77078)
• Blood creatinine level (HCPCS:82565)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)

The enumeration date for this NPI number is 9/7/2005 and was last updated on 3/14/2012.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.